| Announce Date | 11/19/2025 |
| EPS Normalized Actual | $1.28 (Beat by $0.05) |
| EPS GAAP Actual | $1.28 (Beat by $0.05) |
| Revenue Actual | $15.117B |
| Revenue Surprise | Beat by $15117M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 6.795 | 23 | 6.66032 | 6.91793 | 1 |
| Feb 2030 | 6.795 | 23 | 6.6601 | 6.92192 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.28 | 1.28 | 15.117B | 6.97% | 15117M |
| FQ3 2025 (Aug 2025) | 1.1 | 1.1 | 14.401B | 6.48% | 14401M |
| FQ2 2025 (May 2025) | 0.92 | 0.92 | 13.111B | 4.82% | 13111M |
| FQ1 2025 (Feb 2025) | 1.23 | 1.23 | 16.35B | -0.37% | 16350M |
| FQ4 2024 (Nov 2024) | 1.14 | 1.14 | 14.063B | 5.67% | 14063M |
| FQ3 2024 (Aug 2024) | 0.96 | 0.96 | 13.468B | 5.27% | 13468M |
| FQ2 2024 (Apr 2024) | 0.93 | 0.93 | 12.479B | 5.58% | 12479M |
| FQ1 2024 (Jan 2024) | 1.22 | 1.22 | 16.411B | 11.52% | 16411M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 1.69715 | -- | 1.67344 | 1.7261 | 5 |
| FQ4 2027 (Nov 2027) | 1.53441 | -- | 1.51755 | 1.55033 | 4 |
| FQ3 2027 (Aug 2027) | 1.32637 | -- | 1.31179 | 1.34013 | 4 |
| FQ2 2027 (May 2027) | 1.09936 | -- | 1.08728 | 1.11077 | 4 |
| FQ1 2027 (Feb 2027) | 1.4766 | -- | 1.45711 | 1.5039 | 6 |
| FQ4 2026 (Nov 2026) | 1.33633 | 4.22 | 1.31869 | 1.36103 | 6 |
| FQ3 2026 (Aug 2026) | 1.19524 | 7.97 | 1.17529 | 1.22471 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 21.15B | -- | 20.92B | 21.43B | 4 |
| FQ4 2027 (Nov 2027) | 20.56B | -- | 20.38B | 20.72B | 2 |
| FQ3 2027 (Aug 2027) | 19.78B | -- | 19.61B | 19.94B | 2 |
| FQ2 2027 (May 2027) | 19.04B | -- | 18.88B | 19.19B | 2 |
| FQ1 2027 (Feb 2027) | 17.87B | -- | 17.68B | 18.12B | 9 |
| FQ4 2026 (Nov 2026) | 15.32B | 1.32 | 15.16B | 15.54B | 13 |
| FQ3 2026 (Aug 2026) | 16.58B | 13.17 | 16.37B | 16.9B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.28 | 1.28 | 100% | |
| FQ3 2025 (Aug 2025) | 1.1 | 1.1 | 100% | |
| FQ2 2025 (May 2025) | 0.92 | 0.92 | 100% | |
| FQ1 2025 (Feb 2025) | 1.23 | 1.23 | 100% | |
| FQ4 2024 (Nov 2024) | 1.14 | 1.14 | 100% | |
| FQ3 2024 (Aug 2024) | 0.96 | 0.96 | 100% | |
| FQ2 2024 (Apr 2024) | 0.93 | 0.93 | 100% | |
| FQ1 2024 (Jan 2024) | 1.22 | 1.22 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $15.12B | $15117M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $14.4B | $14401M | 100% |
| FQ2 2025 (May 2025) | $0B | $13.11B | $13111M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $16.35B | $16350M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $14.06B | $14063M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $13.47B | $13468M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $12.48B | $12479M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $16.41B | $16411M | 100% |